SOTIO
@sotio.com
SOTIO is developing the next generation of potent immunotherapies for patients with cancer.
SOTIO's Company Logos
SOTIO's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#009BE0
Cerulean
0, 155, 224
198, 100, 44
100, 31, 0, 12
#84B4E2
Cornflower
132, 180, 226
209, 62, 70
42, 20, 0, 11
#00145F
Midnight Blue
0, 20, 95
227, 100, 19
100, 79, 0, 63
About SOTIO
SOTIO Biotech is a pioneering brand that is revolutionizing cancer immunotherapies. With a strong focus on translating cutting-edge science into tangible patient benefits, SOTIO is shaping the future of cancer treatment. At the heart of SOTIO's success is their robust clinical pipeline, which features a range of innovative therapies.
This includes an exceptional IL-15 superagonist, a highly promising immuno-oncology target. SOTIO also employs a proprietary technology that enhances the efficacy of CAR T therapies, as well as a new generation of potent and stable antibody-drug conjugates (ADCs). To expand their portfolio, SOTIO actively pursues promising early-stage candidates through strategic licensing, M&A, and in-house discovery efforts.
The company possesses the necessary capabilities for research, preclinical and clinical development, commercial planning, and market access. They are dedicated to advancing their programs rapidly through clinical development with the ultimate goal of commercialization. SOTIO is committed to pushing the boundaries of cancer treatment and providing hope for patients worldwide
Company type
Privately Held
Year founded
2010
Company size
201-500 employees
